m6A-centered Disease Response Information
General Information of the Disease (ID: M6ADIS0052)
Name |
Liposarcoma
|
||||
---|---|---|---|---|---|
ICD |
ICD-11: 2B59
|
Full List of Target Gene(s) of This m6A-centered Disease Response
PncRNA-D
In total 2 item(s) under this target gene | ||||
Experiment 1 Reporting the m6A-centered Disease Response by This Target Gene | [1] | |||
Response Summary | Knockdown of METTL3 prolonged the half-life of PncRNA-D, and among the known m6A recognition proteins, YTHDC1 was responsible for binding m6A of pncRNA-D Knockdown of METTL3 or YTHDC1 also enhanced the interaction of pncRNA-D with TLS, and results from RNA pulldown assays implicated YTHDC1 in the inhibitory effect on the TLS-pncRNA-D interaction. | |||
Responsed Disease | Liposarcoma [ICD-11: 2B59] | |||
Target Regulator | YTH domain-containing protein 1 (YTHDC1) | READER | ||
Target Regulation | Down regulation | |||
Pathway Response | Cell cycle | hsa04110 | ||
Cell Process | Cell cycle | |||
In-vitro Model | HAP1 | Chronic myelogenous leukemia | Homo sapiens | CVCL_Y019 |
HeLa | Endocervical adenocarcinoma | Homo sapiens | CVCL_0030 | |
In-vivo Model | , | |||
Experiment 2 Reporting the m6A-centered Disease Response by This Target Gene | [1] | |||
Response Summary | Knockdown of METTL3 prolonged the half-life of PncRNA-D, and among the known m6A recognition proteins, YTHDC1 was responsible for binding m6A of pncRNA-D Knockdown of METTL3 or YTHDC1 also enhanced the interaction of pncRNA-D with TLS, and results from RNA pulldown assays implicated YTHDC1 in the inhibitory effect on the TLS-pncRNA-D interaction. | |||
Responsed Disease | Liposarcoma [ICD-11: 2B59] | |||
Target Regulator | Methyltransferase-like 3 (METTL3) | WRITER | ||
Target Regulation | Down regulation | |||
Pathway Response | Cell cycle | hsa04110 | ||
Cell Process | Cell cycle | |||
In-vitro Model | HAP1 | Chronic myelogenous leukemia | Homo sapiens | CVCL_Y019 |
HeLa | Endocervical adenocarcinoma | Homo sapiens | CVCL_0030 | |
In-vivo Model | , | |||